BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hosseini SY, Sanaei N, Fattahi MR, Malek-Hosseini SA, Sarvari J. Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients. Ann Hepatol 2019;18:640-5. [PMID: 31105017 DOI: 10.1016/j.aohep.2018.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Jeong GU, Ahn BY, Jung J, Kim H, Kim TH, Kim W, Lee A, Lee K, Kim JH. A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants. PLoS One 2020;15:e0236704. [PMID: 32790777 DOI: 10.1371/journal.pone.0236704] [Reference Citation Analysis]
2 Gao L, Hu Y, Shi X, Li X, Zhang D, Ren H. 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients. Ann Hepatol 2020;19:329-34. [PMID: 31884016 DOI: 10.1016/j.aohep.2019.10.006] [Reference Citation Analysis]
3 Dehghani B, Dehghani A, Sarvari J. Knowledge and Awareness Regarding Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses Among College Students: A Report From Iran. Int Q Community Health Educ 2020;41:15-23. [PMID: 31876257 DOI: 10.1177/0272684X19896727] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Elgaml A, Elegezy M, El-Mesery M, El-Mowafy M. Natural variability in surface antigen and reverse transcriptase domain of hepatitis B virus in treatment-naïve chronic HBV-infected Egyptian patients. Virus Res 2021;302:198422. [PMID: 33836203 DOI: 10.1016/j.virusres.2021.198422] [Reference Citation Analysis]